What does CUSIP 62856X102 represent in this 13F holders report?

CUSIP 62856X102 is the security identifier for MYMD - MYMD PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held MYMD - MYMD PHARMACEUTICALS INC - COM in Q3 2023?

46 institutional investors reported MYMD - MYMD PHARMACEUTICALS INC - COM for Q3 2023. Use the holders table for investor-level position and value details.

MYMD PHARMACEUTICALS INC - COM (MYMD)

CUSIP: 62856X102

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / COM
Total 13F shares: 4,239,671
Total 13F value: $2,509,600
Share change: -85,127
Put/Call ratio: 416%
SEC-reported price per share: $0.59
Number of holders: 46
Value change: -$177,263
Number of buys: 21
Number of sells: 17

Security key

62856X102

Report period

Q3 2023

Institutions

Top holders

MYMD full security history Ownership snapshot Full 13F holder table Q/C TECHNOLOGIES, INC. SEC filings Q/C TECHNOLOGIES, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MYMD - MYMD PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

0/15

Latest evidence

24 Aug 2023

13F 3/4/5 Highest disclosed value: $2,187,443 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $2.19M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Disclosed position value Top 5

VANGUARD GROUP INC $2.19M

Mirae Asset Global Investments Co... $1.78M

Paul Rivard $444K

GEODE CAPITAL MANAGEMENT, LLC $423.4K

BlackRock Finance, Inc. $316.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$2,187,443 1,458,295 shares	—	30 Jun 2023
Mirae Asset Global Investments Co., Ltd.	13F Company 13F	— denominator unverified	$1,775,425 1,183,616 shares	—	30 Jun 2023
Paul Rivard	3/4/5 Chief Legal Officer 3/4/5	— denominator unverified	$444,000 400,000 shares	—	24 Aug 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$423,375 282,250 shares	—	30 Jun 2023
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$316,448 210,965 shares	—	30 Jun 2023
WELLS FARGO & COMPANY/MN	13F Company 13F	— denominator unverified	$244,867 163,244 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

4,239,671

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %